Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 106601-106650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03104517
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
PHASE3Active, not recruiting
96 participants
Started: Apr 23, 2019 · Completed: Sep 30, 2027
1 condition1 sponsor21 locations
NCT05412537
The Impact of Motivation in Return to Work After Work Disability
NAActive, not recruiting
272 participants
Started: Apr 23, 2019 · Completed: Dec 27, 2025
4 conditions2 sponsors1 location
NCT04639622
GENetic Fronto Temporal Dementia Initiative in Lille
NARecruiting
20 participants
Started: Apr 23, 2019 · Completed: Apr 23, 2026
1 condition1 sponsor1 location
NCT03884543
Driving Pressure During General Anesthesia for Open Abdominal Surgery
NAActive, not recruiting
1,468 participants
Started: Apr 23, 2019 · Completed: Jun 30, 2025
1 condition33 sponsors22 locations
NCT04310826
Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy
NAActive, not recruiting
26 participants
Started: Apr 23, 2019 · Completed: Apr 1, 2026
1 condition2 sponsors1 location
NCT03710421
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
PHASE1Recruiting
30 participants
Started: Apr 23, 2019 · Completed: Mar 24, 2026
2 conditions2 sponsors1 location
NCT03853915
FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)
NARecruiting
64 participants
Started: Apr 23, 2019 · Completed: Dec 30, 2026
1 condition2 sponsors1 location
NCT03635632
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
PHASE1Active, not recruiting
94 participants
Started: Apr 23, 2019 · Completed: May 16, 2038
7 conditions4 sponsors2 locations
NCT03581136
Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod
NAActive, not recruiting
74 participants
Started: Apr 22, 2019 · Completed: Jun 28, 2030
1 condition1 sponsor2 locations
NCT05527509
Risk and Resiliency Factors in the RCMP: A Prospective Investigation
NARecruiting
960 participants
Started: Apr 22, 2019 · Completed: Dec 31, 2029
8 conditions5 sponsors1 location
NCT03824652
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
PHASE2Recruiting
50 participants
Started: Apr 22, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT03684447
Neural and Antidepressant Effects of Propofol
PHASE2/PHASE3Active, not recruiting
48 participants
Started: Apr 21, 2019 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT03965611
Evolution of Oropharyngeal and Rectal Microbiota After Severe Traumatic Brain Injury
N/AActive, not recruiting
58 participants
Started: Apr 21, 2019 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT03752840
Village-Integrated Eye Worker Trial II
NARecruiting
60,200 participants
Started: Apr 21, 2019 · Completed: Aug 31, 2029
3 conditions2 sponsors1 location
NCT04271943
THE EFFECT OF AEROBIC AND GAME BASED EXERCISES ON COGNITIVE FUNCTIONS IN DEMENTIA
NAActive, not recruiting
30 participants
Started: Apr 20, 2019 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT04135456
The Optimal Dose of Mannitol for Intraoperative Brain Relaxation During the Operation of Aneurysmal Subarachnoid Hemorrhage
PHASE1/PHASE2Active, not recruiting
99 participants
Started: Apr 20, 2019 · Completed: Jan 14, 2024
1 condition1 sponsor1 location
NCT03835767
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
PHASE2Recruiting
200 participants
Started: Apr 19, 2019 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05906407
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
N/ARecruiting
2,000 participants
Started: Apr 19, 2019 · Completed: Dec 31, 2028
2 conditions3 sponsors12 locations
NCT04599192
Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
N/AEnrolling by invitation
500 participants
Started: Apr 19, 2019 · Completed: Apr 19, 2025
5 conditions1 sponsor1 location
NCT03970005
Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis
N/AEnrolling by invitation
100 participants
Started: Apr 19, 2019 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04042922
High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NAActive, not recruiting
80 participants
Started: Apr 19, 2019 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT04204863
Status Epilepticus Population Study (STEPS)
N/ARecruiting
1,000 participants
Started: Apr 19, 2019 · Completed: Dec 31, 2050
1 condition1 sponsor2 locations
NCT03991169
Oral Iron in Children With Chronic Kidney Disease
PHASE4Recruiting
40 participants
Started: Apr 19, 2019 · Completed: Dec 31, 2028
2 conditions2 sponsors2 locations
NCT06138483
A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
N/ARecruiting
267 participants
Started: Apr 19, 2019 · Completed: Jun 30, 2025
1 condition1 sponsor5 locations
NCT03674047
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
PHASE2Active, not recruiting
50 participants
Started: Apr 19, 2019 · Completed: Aug 31, 2025
1 condition2 sponsors7 locations
NCT03912207
Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults
PHASE1Active, not recruiting
94 participants
Started: Apr 19, 2019 · Completed: Jun 30, 2024
1 condition4 sponsors2 locations
NCT06321653
Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
N/ARecruiting
120 participants
Started: Apr 18, 2019 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT03922035
CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant
PHASE1Active, not recruiting
36 participants
Started: Apr 18, 2019 · Completed: Mar 4, 2026
1 condition2 sponsors1 location
NCT04975724
Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder
PHASE4Recruiting
150 participants
Started: Apr 18, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor12 locations
NCT03903120
ASSIST: Treatment for Childhood Apraxia of Speech
PHASE1Active, not recruiting
420 participants
Started: Apr 18, 2019 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT03922724
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
PHASE2Recruiting
330 participants
Started: Apr 18, 2019 · Completed: Oct 31, 2030
3 conditions1 sponsor2 locations
NCT04082689
Bowel And Bladder Function in Infant Toilet Training
NAActive, not recruiting
293 participants
Started: Apr 18, 2019 · Completed: Sep 30, 2025
4 conditions4 sponsors6 locations
NCT03974893
Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia
N/AActive, not recruiting
115 participants
Started: Apr 18, 2019 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT03878121
Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
PHASE1Recruiting
300 participants
Started: Apr 17, 2019 · Completed: Oct 15, 2025
1 condition1 sponsor1 location
NCT04631133
LISA Post Market Clinical Follow-Up Study: Documentation of Clinical Outcomes After Surgery With LISA Implant
N/ARecruiting
136 participants
Started: Apr 17, 2019 · Completed: Dec 31, 2028
4 conditions1 sponsor5 locations
NCT03519269
Navio Robotic Versus Conventional Total Knee Arthroplasty
NARecruiting
86 participants
Started: Apr 17, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03964532
TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Apr 17, 2019 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT03910387
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer
PHASE2Active, not recruiting
22 participants
Started: Apr 17, 2019 · Completed: Oct 1, 2024
5 conditions3 sponsors3 locations
NCT03875287
Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors
PHASE1Recruiting
35 participants
Started: Apr 17, 2019 · Completed: Dec 1, 2026
1 condition2 sponsors2 locations
NCT03718637
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
PHASE4Recruiting
40 participants
Started: Apr 17, 2019 · Completed: Jan 17, 2027
2 conditions2 sponsors1 location
NCT03806608
Evaluation of MBL Around Implants Placed in Crestal or Subcrestal Positions: a RCT
NAActive, not recruiting
20 participants
Started: Apr 17, 2019 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT03922893
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
N/ARecruiting
1,500 participants
Started: Apr 17, 2019 · Completed: Apr 30, 2029
1 condition1 sponsor7 locations
NCT03900494
Comparing the Efficacy of Two Valved Holding Chambers in Acute Wheezing
NARecruiting
80 participants
Started: Apr 17, 2019 · Completed: Dec 31, 2028
3 conditions5 sponsors4 locations
NCT04170244
Skin Microbial Ecology in Atopic Dermatitis
N/ARecruiting
240 participants
Started: Apr 17, 2019 · Completed: Apr 1, 2027
3 conditions1 sponsor1 location
NCT03918070
Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems
N/AActive, not recruiting
2,722 participants
Started: Apr 17, 2019 · Completed: May 24, 2024
1 condition2 sponsors19 locations
NCT03545386
Fecal Microbiota Transplantation for Pouchitis
PHASE2Recruiting
34 participants
Started: Apr 17, 2019 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT03851484
Sensory Symptoms in Tourette Syndrome
N/ARecruiting
214 participants
Started: Apr 17, 2019 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT03911973
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
PHASE1/PHASE2Active, not recruiting
37 participants
Started: Apr 17, 2019 · Completed: Jul 31, 2024
1 condition3 sponsors5 locations
NCT03709446
Leflunomide in Previously Treated Metastatic Triple Negative Cancers
PHASE1/PHASE2Active, not recruiting
17 participants
Started: Apr 16, 2019 · Completed: Nov 30, 2025
3 conditions1 sponsor3 locations
NCT03922542
Comparison of Standard vs. Accelerated Corneal Crosslinking
PHASE2/PHASE3Recruiting
510 participants
Started: Apr 16, 2019 · Completed: Jul 1, 2026
2 conditions1 sponsor1 location